Spyre Therapeutics Inc. (NASDAQ: SYRE) Stock Information | RedChip

Spyre Therapeutics Inc. (NASDAQ: SYRE)


$27.5550
-0.1450 ( -2.50% ) 188.9K

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.

Market Data


Open


$27.5550

Previous close


$27.7000

Volume


188.9K

Market cap


N/A

Day range


$27.3310 - $31.4000

52 week range


$10.4200 - $47.9700

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Nov 19, 2024
10-q/a Quarterly Reports 74 Nov 18, 2024
10-k/a Quarterly Reports 108 Nov 18, 2024
10-q/a Quarterly Reports 68 Nov 18, 2024
8-k 8K-related 13 Nov 18, 2024
10-q/a Quarterly Reports 77 Nov 18, 2024
8-k 8K-related 47 Nov 12, 2024
4 Insider transactions 1 Nov 08, 2024
8-k 8K-related 15 Nov 07, 2024
10-q Quarterly Reports 88 Nov 07, 2024

Latest News